000403.SZ
Pacific Shuanglin Bio-pharmacy Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 9.47
−0.84%Next report
Analyst consensus
- Next report date
- Apr 23, 2027
- EPS estimate
- CNY 0.11
- Revenue estimate
- —
Latest reported
- Last report date
- Oct 22, 2026
- EPS actual
- CNY 0.07
- EPS estimate
- CNY 0.28
- Revenue actual
- CNY 573.3M
- Revenue estimate
- CNY 573.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -73.6%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 22, 2026 | CNY 0.28 | CNY 0.07 | Miss -74.74% | CNY 573.3M |
| Aug 24, 2026 | CNY 0.24 | CNY 0.07 | Miss -72.49% | CNY 486.9M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Apr 23, 2027